Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study-Reference-Cited by-同舟云学术

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study

Published:2015-03-31 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Tikk Kaja,Sookthai Disorn,Fortner Renée T,Johnson Theron,Rinaldi Sabina,Romieu Isabelle,Tjønneland Anne,Olsen Anja,Overvad Kim,Clavel-Chapelon Françoise,Baglietto Laura,Boeing Heiner,Trichopoulou Antonia,Lagiou Pagona,Trichopoulos Dimitrios,Masala Giovanna,Krogh Vittorio,Tumino Rosario,Ricceri Fulvio,Mattiello Amalia,Agudo Antonio,Menéndez Virginia,Sánchez María-José,Amiano Pilar,Chirlaque Maria-Dolores,Barricarte Aurelio,Bueno-de-Mesquita HBas,Monninkhof Evelyn M,Onland-Moret N Charlotte,Andresson Anne,Sund Malin,Weiderpass Elisabete,Khaw Kay-Tee,Key Timothy J,Travis Ruth C,Merritt Melissa A,Riboli Elio,Dossus Laure,Kaaks Rudolf

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0563-6.pdf

Reference24 articles.

1. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96:906–20.

2. Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103:2481–4.

3. Jones JL. Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast Cancer Res. 2006;8:204.

4. Reeves GK, Pirie K, Green J, Bull D, Beral V, For the Million Women Study C. Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131:930–7.

5. Tikk K, Sookthai D, Johnson T, Rinaldi S, Romieu I, Tjønneland A, et al. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Ann Oncol. 2014;25:1422–8.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel FFPE proteomics method suggests prolactin induced protein as hormone induced cytoskeleton remodeling spatial biomarker;Communications Biology;2024-06-08

2. Dual role of pregnancy in breast cancer risk;General and Comparative Endocrinology;2024-06

3. Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice;Critical Reviews in Toxicology;2024-02-07

4. The Cell Transformation Assay: A Historical Assessment of Current Knowledge of Applications in an Integrated Approach to Testing and Assessment for Non-Genotoxic Carcinogens;International Journal of Molecular Sciences;2023-03-16

5. Impact of the prolactin levels in breast cancer: a systematic review and meta-analysis;Gynecological Endocrinology;2022-03-10